Reinforcing its commitment to providing a better life for sensitive skin, La Roche-Posay has launched EFFACLAR SPOTSCAN – the world’s first acne diagnosis tool powered by advanced artificial intelligence, designed specifically for people with oily, acne-prone skin only. Available for use in Australia, the diagnostic tool accessible via a website using a smartphone has been developed with the help of leading dermatologists to support people with acne-prone skin, accurately diagnosing pimples, blackheads and pigmented marks to provide an acne grade, personalising product solutions and enabling guided follow up.
Created as an extremely high-tech introduction to La Roche-Posay’s EFFACLAR range, a 10-product skincare range formulated especially for oily, acne-prone skin, EFFACLAR SPOTSCAN is a first step for acne sufferers to learn about their acne grading, and access a personalised skincare regime based off their results – in the comfort of their own home.
To build the most accurate and validated algorithm, La Roche-Posay engaged five dermatologists and three expert clinical research organisations from around the world to analyse more than 6,000 images of men and women representing different ethnicities, skin types and levels of acne severity. The collated data was provided to La Roche-Posay’s scientific direction and artificial intelligence development teams, to build an algorithm that would reach an accuracy level comparable to that of dermatologists’ face-to-face evaluations, although not intended to replace these expert consultations.
After two years of trialling and improvements to the algorithm, La Roche-Posay successfully reached an accuracy level on par with some dermatologists’ initial acne consultations. EFFACLAR SPOTSCAN is now a true example of health and artificial intelligence joining forces to benefit patients as well as healthcare professionals like dermatologists and GPs in the fight against acne.
HOW EFFACLAR SPOTSCAN WORKS
The EFFACLAR SPOTSCAN diagnosis begins when the user takes three photos of their face, at close range on a smartphone camera. Within a few minutes, the tool identifies the user’s skin condition by counting the number of acne lesions (including: inflammatory lesions such as red spots and white heads; retentional lesions such as blackheads and pimples; and pigmented and coloured marks such as pigmentation) and comparing them to the global acne evaluation scale to determine the user’s ‘acne grade’ from 0 to 4+.
Based on the diagnosis, the results outline a personalised La Roche-Posay EFFACLAR routine with specific skincare tips. Those who receive an acne grade of 2 or above are advised to see a dermatologist. Following the recommendation, EFFACLAR SPOTSCAN encourages the user to try the ‘before and after’ Skin Diary to track their progress over time and as their skin improves (provided the user doesn’t clear their web browser cookies).
EFFACLAR SPOTSCAN will provide users with one of five La Roche-Posay EFFACLAR skincare regimes and includes:
EFFACLAR K (+) Anti-Blackhead Care (RRP $31.95)
EFFACLAR H Hydrating Cleansing Cream (RRP $27.95)
EFFACLAR H Soothing Moisturiser (RRP $31.95)
Visit www.laroche-posay.com.au for more information on La Roche-Posay’s EFFACLAR range and regimes.